» Authors » Simon Harrison

Simon Harrison

Explore the profile of Simon Harrison including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 75
Citations 611
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chung H, Krishnasamy M, Joyce T, Dryden T, Whitechurch A, Baden P, et al.
Vaccine . 2025 Feb; 50:126826. PMID: 39893769
Background: People affected by haematological malignancies are at high risk of morbidity and mortality caused by vaccine-preventable infections. However, vaccination commencement and completion following anti-cancer treatment is sub-optimal for this...
2.
Conley T, Kopczynska M, Harrison S, Lonsdale H, Barrett M, Lal S
Clin Nutr ESPEN . 2025 Jan; 66():46-50. PMID: 39800137
Background & Aims: Current estimates of the prevalence of iron deficiency anaemia (IDA) in patients with chronic intestinal failure (CIF) exceed those seen in general population, however, the studies to-date...
3.
Murphy D, Weatherill J, Henriques R, Quishi X, Harrison S
J Environ Manage . 2025 Jan; 373():123858. PMID: 39742764
Nature-based Solutions (NbS) are widely advocated to have multiple benefits, including in flood risk reduction, water quality improvement and ecosystem health. There are, however, few empirical studies quantifying such multi-functionality....
4.
Jones D, Allsopp K, Sowerbutts A, Lal S, Farrer K, Harrison S, et al.
Nutrients . 2024 Nov; 16(22). PMID: 39599751
Background: Parenteral nutrition (PN) is required by people with intestinal failure and can be delivered as multi-chambered bags (MCBs) or individually compounded (COM) bags. This systematic review aimed to examine...
5.
Farrer K, Kopczynska M, Barrett M, Harrison S, Teubner A, Abraham A, et al.
JPEN J Parenter Enteral Nutr . 2024 Nov; 49(1):85-93. PMID: 39521933
Background: Chyme reinfusion therapy treats patients with high-output fistulas or stomas by returning chyme to the distal gut. The role of this treatment in severe acute intestinal failure is currently...
6.
Kopczynska M, Harrison S, Farrer K, Leahy G, Ollerenshaw-Ward C, Lal S
Clin Nutr ESPEN . 2024 Sep; 64:66-72. PMID: 39299608
Background & Aims: There is varied international practice in the use of ready-made multi-chamber bags (MCBs) and compounded parenteral nutrition (PN). Recent national aseptic pharmacy capacity limitations have restricted compounded...
7.
Gichuru W, Abinya N, Odhiambo A, Otieno F, Harrison S, Ongondi M
Adv Hematol . 2024 Feb; 2024:3208717. PMID: 38375211
Background: Multiple myeloma (MM) is a chronic B-cell malignancy that involves proliferation of neoplastic clonal plasma cells in the bone marrow with circulating monoclonal immunoglobulins or constituent chains in serum...
8.
Guy L, Caceres G, Jackson T, Gorman S, Wilson J, Hsieh Y, et al.
J Neurol . 2023 Dec; 271(4):1873-1884. PMID: 38091087
Objectives: We report routinely collected outcome data from an 8-week outpatient rehabilitative therapy program. The aims of the intervention were to (1) reduce symptom severity and (2) improve functional mobility...
9.
Sales C, Anderson M, Kuznetsova V, Rosenfeld H, Malpas C, Roos I, et al.
Eur J Neurol . 2023 Dec; 31(3):e16174. PMID: 38085272
Background And Purpose: Immune effector cell-associated neurotoxicity syndrome (ICANS) is an important complication of chimeric antigen receptor T-cell (CAR-T) therapy. This study aims to identify the patterns of neurotoxicity among...
10.
Hall V, Saunders N, Klimevski E, Tennakoon G, Khot A, Harrison S, et al.
Open Forum Infect Dis . 2023 Oct; 10(10):ofad497. PMID: 37869409
In patients early post-autologous stem cell transplant, seroprotection rates were high for type B and tetanus toxoid (70%-90%) but lower for (30%-50%) including after revaccination. There were high rates of...